PYRIDOXINE HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for pyridoxine hydrochloride and what is the scope of patent protection?
Pyridoxine hydrochloride
is the generic ingredient in two branded drugs marketed by Lilly, Bel Mar, Dell Labs, Dr Reddys, Elkins Sinn, Epic Pharma Llc, Fresenius Kabi Usa, Luitpold, Mylan Institutional, and Watson Labs, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for pyridoxine hydrochloride. Two suppliers are listed for this compound.
Summary for PYRIDOXINE HYDROCHLORIDE
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 10 |
NDAs: | 11 |
Drug Master File Entries: | 4 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 146 |
Clinical Trials: | 80 |
Patent Applications: | 6,515 |
What excipients (inactive ingredients) are in PYRIDOXINE HYDROCHLORIDE? | PYRIDOXINE HYDROCHLORIDE excipients list |
DailyMed Link: | PYRIDOXINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for PYRIDOXINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Anahuac University | N/A |
Valenta Pharm JSC | N/A |
All India Institute of Medical Sciences, New Delhi | Phase 2/Phase 3 |
Pharmacology for PYRIDOXINE HYDROCHLORIDE
Ingredient-type | Analogs/Derivatives Vitamin B 6 |
Drug Class | Vitamin B6 Analog |
Medical Subject Heading (MeSH) Categories for PYRIDOXINE HYDROCHLORIDE
US Patents and Regulatory Information for PYRIDOXINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dell Labs | PYRIDOXINE HYDROCHLORIDE | pyridoxine hydrochloride | INJECTABLE;INJECTION | 083772-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Dr Reddys | PYRIDOXINE HYDROCHLORIDE | pyridoxine hydrochloride | INJECTABLE;INJECTION | 080572-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Lilly | HEXA-BETALIN | pyridoxine hydrochloride | INJECTABLE;INJECTION | 080854-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Epic Pharma Llc | PYRIDOXINE HYDROCHLORIDE | pyridoxine hydrochloride | INJECTABLE;INJECTION | 087967-001 | Oct 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Luitpold | PYRIDOXINE HYDROCHLORIDE | pyridoxine hydrochloride | INJECTABLE;INJECTION | 080669-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
PYRIDOXINE HYDROCHLORIDE Market Analysis and Financial Projection Experimental
More… ↓
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.